Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) General Information

Description

Patent Portfolio of Interleukin 1 Receptor Accessory Protein located in The United States of America. The IL1RAP is used for cancer therapy patients that consists of stimulation of immune cells to eradicate cancer cells as well as blockade of interleukin 1 signaling.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 1531 Industrial Road
  • San Carlos, CA 94070
  • United States
Primary Industry
Buildings and Property
Other Industries
Drug Delivery
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 1531 Industrial Road
  • San Carlos, CA 94070
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)‘s full profile, request access.

Request a free trial

Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)‘s full profile, request access.

Request a free trial

Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) FAQs

  • Where is Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) headquartered?

    Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) is headquartered in San Carlos, CA.

  • What industry is Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) in?

    Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)’s primary industry is Buildings and Property.

  • Is Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) a private or public company?

    Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) is a Private company.

  • What is Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)’s current revenue?

    The current revenue for Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) is .

  • Who are Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)’s investors?

    Cellerant Therapeutics has invested in Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein).

  • When was Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) acquired?

    Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) was acquired on 10-Mar-2020.

  • Who acquired Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein)?

    Cellerant Therapeutics (Patent Portfolio of Interleukin 1 Receptor Accessory Protein) was acquired by Cantargia.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process